Charles River Laboratories International, Inc. News Headlines

CRL 
$56.8
*  
0.21
 negative 
0.37%
Get CRL Alerts
*Delayed - data as of Apr. 15, 2014 
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

sNDA Resubmitted for Bayer/JNJ drug - Analyst Blog
9/10/2012 3:15:01 PM - Zacks.com

Charles River Purchases Accugenix - Analyst Blog
8/31/2012 6:30:01 PM - Zacks.com

Good News for Alexza Pharma - Analyst Blog
8/23/2012 10:32:39 AM - Zacks.com

Salix Pharma at Neutral - Analyst Blog
8/21/2012 5:30:01 PM - Zacks.com

Earnings Beat for Salix, EPS View Up - Analyst Blog
8/13/2012 10:21:21 AM - Zacks.com

Earnings Beat at CRL, View Adjusted - Analyst Blog
8/9/2012 3:21:14 PM - Zacks.com

VPHM Manufacturing Process Approved - Analyst Blog
8/7/2012 7:17:01 PM - Zacks.com

Regeneron Gets CRL - Analyst Blog
7/31/2012 5:27:12 PM - Zacks.com

Positive Data on Alnylam Candidate - Analyst Blog
7/23/2012 5:09:37 PM - Zacks.com

Glory for Vivus After Arena - Analyst Blog
7/18/2012 2:09:09 PM - Zacks.com

Human Genome Resubmits BLA - Analyst Blog
7/11/2012 5:47:15 PM - Zacks.com

Speedy Review for Bayer/JNJ Drug - Analyst Blog
7/11/2012 4:47:42 PM - Zacks.com

Setback for Chelsea Therapeutics - Analyst Blog
7/6/2012 6:29:01 PM - Zacks.com

Second Time Lucky for Arena's Belviq - Analyst Blog
6/29/2012 10:12:38 AM - Zacks.com

CRL for Repligen Candidate - Analyst Blog
6/28/2012 5:12:16 PM - Zacks.com

Bristol-Myers/Pfizer get CRL - Analyst Blog
6/28/2012 10:11:16 AM - Zacks.com

ITMN Concludes Sale of Actimmune - Analyst Blog
6/22/2012 4:12:59 PM - Zacks.com

Setback for Pfizer Candidate - Analyst Blog
6/19/2012 3:54:31 PM - Zacks.com

Theravance Kept at Neutral - Analyst Blog
6/19/2012 9:52:05 AM - Zacks.com

Good News for Endo's Pain Portfolio - Analyst Blog
6/15/2012 6:48:01 PM - Zacks.com

Third Time's the Charm for Glaxo - Analyst Blog
6/15/2012 1:45:01 PM - Zacks.com

Bristol-Myers Shares Positive Data - Analyst Blog
6/11/2012 9:53:55 AM - Zacks.com

Merck's Drug Fails to Get FDA Nod - Analyst Blog
6/6/2012 9:51:57 AM - Zacks.com

Eli Lilly Launches Amyvid - Analyst Blog
6/4/2012 5:51:55 PM - Zacks.com

Salix Beats; Ups EPS Outlook - Analyst Blog
5/8/2012 11:15:24 AM - Zacks.com